Clin2
NCT06695247Likely a fitRecruiting

Walking recovery after serious lung blood clot

Pulmonary Embolism

Part of Heart & circulation, Lungs & breathing clinical trials.

This study follows people who had a serious blood clot in their lungs that also affected their heart's right side. It tests how their ability to walk and move changes over 6 months, helping doctors understand recovery better.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You must be diagnosed with a medium- to high-risk blood clot in your lungs (called a pulmonary embolism) that affected your heart.
  • You need to be able to walk on your own (with or without oxygen during walking).
  • You must not have had a previous blood clot in your lungs, chronic blood clot related lung disease, or pulmonary artery high blood pressure.
  • You must be able to read and understand questionnaires in English and return for visits at 3 and 6 months.
  • You must be able to give written permission to join the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04615130Recruiting
Pulmonary rehab for symptoms after a lung blood clot

This trial studies a structured pulmonary (lung) rehabilitation program for people who still have breathing and activity problems after a pulmonary embolism (PE). It may help improve physical ability and function during recovery.

Vienna
NCT05015153Recruiting
Rehab after blood clot in the lungs to improve daily life

This study looks at whether pulmonary rehabilitation (a supervised exercise and support program for lung recovery) improves quality of life after a lung blood clot. It focuses on people who have ongoing breathing-related limits after treatment with blood thinners.

Brest, France
NCT07603700Not yet recruiting
Treatment strategies for moderate-to-severe blood clots in the lungs

This real-world study compares different treatment approaches for pulmonary embolism (PE)—a serious blood clot in the lung arteries—in patients who are stable but at intermediate-to-high risk of complications. The goal is to understand which treatments work best and safest in everyday practice.

Nanjing, Jiangsu
NCT05591118Recruiting· Phase 3
Catheter treatment to remove blood clots in the lungs

This Phase 3 trial tests a catheter-based procedure to remove a lung blood clot (pulmonary embolism) and reduce strain on the heart. It may help people who have specific CT scan signs of right-heart strain.

Birmingham, Alabama
NCT04355975Recruiting
Study follow-up outcomes after a lung blood clot

This trial looks at how people do after an acute pulmonary embolism (a blood clot in the lungs). It aims to understand real-world outcomes over follow-up and may help improve how care teams track patients after treatment.

Bern, Canton of Bern
NCT06541353Recruiting
Predicting heart function after a pulmonary embolism

This study uses heart signals and blood tests to predict how well your heart will recover over a year after a pulmonary embolism. It may help doctors tailor your care based on your personal risk.

Beijing, Beijing Municipality

Hear when a new Pulmonary Embolism trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.